Aino Health AB (publ): interim report january-march 2024
May 14 2024 - 2:30AM
Aino Health AB (publ): interim report january-march 2024
This document in English is a translation of the original in
Swedish. In case of any discrepancy, the Swedish original will
prevail.
Extending existing contracts. Improved cash
flow.
January – March 2024
• Net sales were KSEK 5 994 (6 180)• Profit/loss after financial
items was KSEK -2 943 (-2 791)• Earnings per share were SEK -0,0
(-0,1)
Recently, we have seen growth within our customer network. I am
delighted to announce that several of our existing customers have
chosen to extend their licences to include even more employees.
This is not only a marker of the success of our platform, but also
a testament to the increasing focus on employee sustainability
among businesses and organisations.Our customers recognise that a
healthy and sustainable work environment is key to long-term
success and growth. Investing in the wellbeing and health of their
employees not only increases company productivity and
profitability, but also strengthens the bonds between employees and
the organisation as a whole. A key factor behind this success is
our technological advances. We have made significant investments in
improving our platform, enabling us to create even more value from
our customers' data. Through advanced analytics and customised
solutions, we can now offer our clients in-depth insights that help
them foster a culture of wellbeing and sustainability in the
workplace. At Aino Health, we are committed to being a trusted
partner to our clients in promoting employee sustainability. We
believe that a healthy and thriving workforce is the foundation of
any successful organisation, and we are proud to support our
clients on their journey towards this goal. Funding of the
business at the moment At the time of publishing the
interim report for the first quarter, a rights issue is planned
with a subscription period in June 2024, but the outcome is not yet
known. The Board of Directors believes that there are good
conditions for the outcome of the planned issue, together with
achieved sales forecasts, to create the conditions for continued
operations for the financial year 2024. Management is aware that
there are uncertainties in these assumptions, but considers the
risks to be manageable and works continuously to overcome them.
The information contained herein is such as shall be made public
by Aino Health AB (publ), in accordance with the EU Market Abuse
Regulation. This information was made public, through the agency of
Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET
on may 14, 2024.
For more informationJyrki EklundCEO Aino
HealthPhone: +358 40 042 4221jyrki.eklund@ainohealth.com
Aino Health AB (publ) is listed on Nasdaq Stockholm First North
Growth Market (Ticker: AINO).
Certified adviserCarnegie Investment Bank AB
(publ)For more information
see: https://investors.ainohealth.com/certified-adviser/
About Aino Health (publ)Aino Health is the
leading provider of Software as a Service solutions in Corporate
Health Management.The company’s complete system of SaaS platforms
and services reduces sick leave, lowers related costs and improves
business outcomes through increased productivity and employee
engagement by making health, well-being and safety an integral part
of daily work. For more information visit ainohealth.com.